CDon says coronavirus latest: children are more likely to spread the infection

The next head of the World Trade Organization needs recent experience of steering through the coronovirus epidemic, argues Yu Myung-hing, a candidate from South Korea. She is One of the eight contenders To succeed Roberto Azevado of Brazil as Director General of the World Trade Organization.
South Africa’s President Cyril Ramaphosa is facing increased pressure to accelerate the reform of the electricity and telecommunications sectors in the continent’s most industrialized economy following the epidemic. Erased for over a decade Delicate development. Gross domestic product fell by about a fifth year on year in the second quarter.
As executives in the $ 600bn reinsurance industry log on video calls later this week, they may be forgiven for thinking of Monaco. They should have gathered in the radiance of the princely state off the coast of France, but the epidemic has made the future of the annual Rendez-vous de Setembre In danger.
In the scoreboard, the return of the US National Football League ticks a critical reevaluation of the start of the clock $ 5bn Media Rights Deals, Wonder about the true value of English Premier League clubs following the promotion of Leeds United and clarify the reasoning behind David Beckham’s bet on an esports team.

UK fashion retailer New Look is set for another confrontation with its landlords next week as it calls for further major cuts in rents with a warning. It can burst without them. The company has about 500 stores and employs over 12,000 people.
Gilead Sciences – in the spotlight for Remedisvir, a drug that received emergency approval to treat Kovid-19 – is close to buying immunomedics for $ 20bn, as the drug group has tried Outbreak rivals Competition to silence cancer drug developer. Gilead’s offer is close to double immunomedics’ value.
Gojek and Grab, Southeast Asia’s biggest start-ups, have resumed negotiations on the merger at the behest of shareholders, including SoftBank, as Japanese group founder Masayoshi Son threw his weight behind a deal. Deliberation resumes as rival Hemorrhage Money due to Kovid-19 ban.

The University of Oxford and AstraZeneca are to resume international clinical trials of their proposed coronaviruses Vaccine candidate. There is speculation that there may be a significant delay in the much-awaited study which is inappropriate. The test was stopped last Sunday when a participant fell ill in the UK.

Leave a Reply